These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
173 related articles for article (PubMed ID: 4359183)
1. Clinical and metabolic effects of pentaerythritol tetranicotinate(Perycit)and a comparison with plain nicotinic acid. Olsson AG; Orö L; Rössner S Atherosclerosis; 1974; 19(1):61-73. PubMed ID: 4359183 [No Abstract] [Full Text] [Related]
2. Clinical and metabolic effects of pentaerythritol tetranicotinate in combination with cholesolvin or clofibrate. Olsson AG; Orö L; Rössner S Atherosclerosis; 1974; 19(3):407-15. PubMed ID: 4364073 [No Abstract] [Full Text] [Related]
3. Triglyceride-lowering effect of chenodeoxycholic acid in patients with endogenous hypertriglyceridaemia. Miller NE; Nestel PJ Lancet; 1974 Oct; 2(7886):929-31. PubMed ID: 4138590 [No Abstract] [Full Text] [Related]
4. Effects of clofibrate, nicotinic acid and diet on the properties of the plasma lipoproteins in a subject with type III hyperlipoproteinemia. Patsch JR; Yeshurun D; Jackson RL; Gotto AM Am J Med; 1977 Dec; 63(6):1001-9. PubMed ID: 204188 [No Abstract] [Full Text] [Related]
5. Effects of oxandrolone on plasma lipoproteins and the intravenous fat tolerance in man. Olsson AG; Orö L; Rössner S Atherosclerosis; 1974; 19(2):337-46. PubMed ID: 4360244 [No Abstract] [Full Text] [Related]
7. Pentaerythritoltetranicotinate (Perycit) in the treatment of hypercholesterolaemia. Sigroth K Acta Med Scand; 1968 Oct; 184(4):269-73. PubMed ID: 5710032 [No Abstract] [Full Text] [Related]
8. [Serum-lipid reducing principles--possibilities for treatment. 5. Indications for nicotinic acid and nicotinic acid derivatives]. Orö L Lakartidningen; 1970 Dec; 67():Suppl IV:63+. PubMed ID: 5511953 [No Abstract] [Full Text] [Related]
10. A physician's guide to hyperlipidemia. Fredrickson DS Mod Concepts Cardiovasc Dis; 1972 Jul; 41(7):31-6. PubMed ID: 4343098 [No Abstract] [Full Text] [Related]
11. A comparative study of a new drug MK 185 with clofibrate in the treatment of hyperlipidaemias. Jepson EM; Small E; Grayson MF; Bance G; Billimoria JD Atherosclerosis; 1972; 16(1):9-14. PubMed ID: 4341723 [No Abstract] [Full Text] [Related]
12. [Familial hyperlipoproteinemia type III]. Patsch JR; Patsch W; Sailer S; Braunsteiner H Dtsch Med Wochenschr; 1976 Oct; 101(44):1612-9. PubMed ID: 185039 [No Abstract] [Full Text] [Related]
13. Treatment of hyperlipidemia. Levy RI; Morganroth J; Rifkind BM N Engl J Med; 1974 Jun; 290(23):1295-301. PubMed ID: 4363888 [No Abstract] [Full Text] [Related]
15. Effects of niceritrol (pentaerythritol tetranicotinate) on plasma lipoprotein concentration: increment of high density lipoprotein(HDL) cholesterol and HDL-cholesterol/low density lipoprotein cholesterol ratio in hypo-high density lipoproteinemia. Oida K; Nakai T; Tamai T; Kutsumi Y; Kobayashi T; Hayashi T; Yamada S; Takeda R Artery; 1982; 10(4):266-85. PubMed ID: 7181672 [TBL] [Abstract][Full Text] [Related]
16. Oral glucose tolerance, plasma insulin, and uric acid excretion in man during chronic administration of nicotinic acid. Gaut ZN; Pocelinko R; Solomon HM; Thomas GB Metabolism; 1971 Nov; 20(11):1031-5. PubMed ID: 5115752 [No Abstract] [Full Text] [Related]
17. A case of massive hypertriglyceridemia corrected by nicotinic acid or nicotinamide therapy. Carlson LA; Fröberg S; Orö L Atherosclerosis; 1972; 16(3):359-68. PubMed ID: 4348602 [No Abstract] [Full Text] [Related]
18. [Treatment of primary hyperlipoproteinaemia types, IIa, IIb, 3 and IV with clofibrate (author's transl)]. von Löwis P; Klemens UH Dtsch Med Wochenschr; 1973 Dec; 98(49):2328-33. PubMed ID: 4357927 [No Abstract] [Full Text] [Related]
19. Long-term use of gemfibrozil (Lopid) in the treatment of dyslipidemia. Lewis JE Angiology; 1982 Sep; 33(9):603-12. PubMed ID: 6957156 [TBL] [Abstract][Full Text] [Related]
20. The effect of niceritrol (pentaerythritoltetranicotinate) and clofibrate upon hyperlipemia and atherosclerosis induced in rabbits by cholesterol-free semisynthetic diets. Brattsand R Atherosclerosis; 1974; 20(3):453-67. PubMed ID: 4373017 [No Abstract] [Full Text] [Related] [Next] [New Search]